The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.

Roche is exceptional among pharma companies in maintaining its own diagnostics business ... research with biomedical know-how in order to develop a new sensor technology platform for near-patient ...